Håkan Mellstedt, M.D., Ph.D. Karolinska University Hospital (Sweden)

Håkan Mellstedt is Professor of Oncologic Biotherapy at the Karolinska Institute and Administrative Director of Cancer Centre Karolinska (CCK) at the Karolinska University Hospital in Stockholm, Sweden. He holds a position as Chief Physician in the Departments of Oncology and Haematology and is board certified in Internal Medicine, Oncology and Haematology.

Dr. Mellstedt has published more than 450 manuscripts in peer-reviewed journals and is the author of numerous oncology chapters in professional medical textbooks. He was awarded the Alfaferone Prize 1989 (Italy) and the J. Waldenström Award 2001 (USA), and he has been invited as a speaker at international meetings more than 170 times.

He was the Chairman of the Swedish Society of Oncology from 1993 - 2000. He was the President of ESMO (European Society for Medical Oncology) Foundation, dedicated to promoting medical training and research for the benefit of cancer patients, from 2006 - 2007. Dr. Mellstedt is serving as Past President and Chairman of the ESMO from 2008 - 2009.

He is Scientific Advisor of the Lundbeck's Foundation (Denmark), Chairman of the Swedish Childhood Cancer Foundation, Scientific Secretary of Cancer Society in Stockholm and King Gustaf 5th Jubilee Foundation, Chairman of the Scientific Committee evaluating medical research at Radiumhospital/Rikshospital Oslo in Norway, and Chairman of the Committee for Clinical Medical Research of the Norwegian Research Council. In addition, he is SAB (science advisory board) member of several biotech and biopharmaceutical companies.

Dr. Mellstedt's main research areas are tumour immunology and immunotherapy with a focus on the development of antibody treatment, cytokine therapy and cancer vaccines in gastrointestinal and chronic B cell malignancies. He has also implemented a program developing targeted therapy using antibodies, small molecules and vaccines for CLL.